The global bio/pharmaceutical outsourcing industry is experiencing a paradigm shift driven by macroeconomic pressures, changing regulatory paradigms, and the rise of asset-light virtual biotechnology firms. As a result of these drivers, bio/pharma innovators are changing the way they evaluate and select CDMOs. Once characterized by tactical, transactional fee-for-service arrangements, the focus is now moving toward deeply integrated, phase-specific, and regionally resilient partnerships.
In the latest From Stem to Stern episode, Mark Santos, Vice President of Commercial Development at FUJIFILM Biotechnologies, Mike Shearer, Chief Commercial Officer at Wilmington PharmaTech, and Mark Macdonald, Technical Sales Director at Codis, sat down with The Pharma Navigator to map out the structural evolution required to bring the next generation of life-saving therapeutics from discovery to patients.
Biotech pipelines are evolving toward complex molecules and next‑generation modalities, leaving little margin for error in primary packaging. Risks like leachables or pH shifts can quickly compromise drug stability and slow down development.
SCHOTT Pharma’s new cartriQ® BioPure sterile glass cartridge is engineered to protect sensitive APIs and reduce formulation risk - from early trials to commercial scale. Designed for confidence at every stage.
Ethyreal Bio Launches to Advance Dual-Targeting Thyroid Therapy
Backed by USD 101 million in cumulative financing, Ethyreal Bio is targeting the shared pathogenic driver of Graves' disease and thyroid eye disease with a differentiated, long-acting subcutaneous antibody.
AI-Designed Universal Coronavirus Vaccine Passes First Human Trial
A novel pan-sarbecovirus vaccine candidate developed by the University of Cambridge and DIOSynVax has demonstrated safety in a Phase I, needle-free clinical trial.
Circio Expands circVec Platform with GenAssist Collaboration
The objective of the joint research collaboration between Circio and GenAssist is to evaluate potential synergy between the companies’ complementary technologies for the development of next-gen AAVs.
Dive into our upcoming events and programs, featuring curated virtual and in-person sessions that offer focused learning, expert insights, and networking opportunities to keep you ahead of the curve in the dynamic bio/pharma industry.
If your company has news, insights, or a press release that deserves a wider audience, we'd love to feature it in an upcoming edition of The Pharma Navigator.
Get in touch to be considered for a future feature.
Navigator Media Ltd, Chester Steam Mill, Steam Mill Street, Chester, Cheshire CH3 5AN, United Kingdom
